Cancer stem cells and tumor microenvironment in radiotherapy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Ionizing radiation (IR) began to be a powerful medical modality soon after Wilhelm Röntgen’s discovery of X-rays in 1895. Today about 60% of cancer patients worldwide receive radiotherapy in their course of cancer control. In the past decades, the technology for precisely delivering tumor IR dose such as stereotactic body radiation therapy (SBRT) has been significantly enhanced, which increases the overall local tumor response and clinical benefit. However, in achieving the goal for long-term cancer control, radiotherapy (RT) has faced several major challenges including the elucidation of the microenvironment causing tumor repopulation and resistance, especially with the most aggressive tumor cells in late phase metastatic lesions. To meet this challenge, a great deal of effort has been devoted to revealing not only the mechanistic insight of tumor heterogeneity, but also the emerging complexity of the irradiated microenvironment. Such new knowledge provides the explanation for the long recognized tumor heterogeneity and tumor cell repopulation, one the major "R"s in tumor radiobiology, which involves cancer stem cells (also termed tumor-imitating cells, cancer stem-like cells, or stem like cancer cells). It is generally accepted that CSCs plays a key role in tumor adaptive radioresistance and are involved in clinical tumor response. The specific cell surface biomarkers as well as the biological topographies of CSCs in many solid tumors have been identified; some of them overlap with those detected in normal stem cells. However, the exact molecular mechanism causing the radioresistant phenotype of CSCs, especially the dynamic nature of CSCs themselves under RT and their communication with the irradiated tumor microenvironment including stromal cells and immune cells, remains to be elucidated. Further elucidation of the complexity of the irradiated local tumor microenvironment in which CSCs reside may generate significant new information to resensitize radioresistant tumor cells and thus to improve therapeutic efficacy. In this chapter, I will describe the general information on normal stem cells, CSCs, CSCs-associated tumor repopulation and energy reprogramming and potential therapeutic targets. The dynamic features of radioresistance-associated factors such as NF-κB and HER2 in some CSCs including breast cancer and GBM will be discussed.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherKluwer Academic Publishers
Pages191-221
Number of pages31
Edition9783319532332
DOIs
StatePublished - Jan 1 2017

Publication series

NameCancer Treatment and Research
Number9783319532332
ISSN (Print)0927-3042

Fingerprint

Stem Cell Niche
Tumor Microenvironment
Neoplastic Stem Cells
Radiotherapy
Neoplasms
Stem Cells
Ionizing Radiation
Radiobiology

Keywords

  • Cancer stem cells
  • Immunoresponse
  • Metabolic reprogramming
  • Microenvironment
  • Radiosensitization
  • Radiotherapy
  • Tumor repopulation
  • Tumor resistance

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Li, J-J. (2017). Cancer stem cells and tumor microenvironment in radiotherapy. In Cancer Treatment and Research (9783319532332 ed., pp. 191-221). (Cancer Treatment and Research; No. 9783319532332). Kluwer Academic Publishers. https://doi.org/10.1007/978-3-319-53235-6_9

Cancer stem cells and tumor microenvironment in radiotherapy. / Li, Jian-Jian.

Cancer Treatment and Research. 9783319532332. ed. Kluwer Academic Publishers, 2017. p. 191-221 (Cancer Treatment and Research; No. 9783319532332).

Research output: Chapter in Book/Report/Conference proceedingChapter

Li, J-J 2017, Cancer stem cells and tumor microenvironment in radiotherapy. in Cancer Treatment and Research. 9783319532332 edn, Cancer Treatment and Research, no. 9783319532332, Kluwer Academic Publishers, pp. 191-221. https://doi.org/10.1007/978-3-319-53235-6_9
Li J-J. Cancer stem cells and tumor microenvironment in radiotherapy. In Cancer Treatment and Research. 9783319532332 ed. Kluwer Academic Publishers. 2017. p. 191-221. (Cancer Treatment and Research; 9783319532332). https://doi.org/10.1007/978-3-319-53235-6_9
Li, Jian-Jian. / Cancer stem cells and tumor microenvironment in radiotherapy. Cancer Treatment and Research. 9783319532332. ed. Kluwer Academic Publishers, 2017. pp. 191-221 (Cancer Treatment and Research; 9783319532332).
@inbook{2452a4e3333c4095a80bd14d155761b3,
title = "Cancer stem cells and tumor microenvironment in radiotherapy",
abstract = "Ionizing radiation (IR) began to be a powerful medical modality soon after Wilhelm R{\"o}ntgen’s discovery of X-rays in 1895. Today about 60{\%} of cancer patients worldwide receive radiotherapy in their course of cancer control. In the past decades, the technology for precisely delivering tumor IR dose such as stereotactic body radiation therapy (SBRT) has been significantly enhanced, which increases the overall local tumor response and clinical benefit. However, in achieving the goal for long-term cancer control, radiotherapy (RT) has faced several major challenges including the elucidation of the microenvironment causing tumor repopulation and resistance, especially with the most aggressive tumor cells in late phase metastatic lesions. To meet this challenge, a great deal of effort has been devoted to revealing not only the mechanistic insight of tumor heterogeneity, but also the emerging complexity of the irradiated microenvironment. Such new knowledge provides the explanation for the long recognized tumor heterogeneity and tumor cell repopulation, one the major {"}R{"}s in tumor radiobiology, which involves cancer stem cells (also termed tumor-imitating cells, cancer stem-like cells, or stem like cancer cells). It is generally accepted that CSCs plays a key role in tumor adaptive radioresistance and are involved in clinical tumor response. The specific cell surface biomarkers as well as the biological topographies of CSCs in many solid tumors have been identified; some of them overlap with those detected in normal stem cells. However, the exact molecular mechanism causing the radioresistant phenotype of CSCs, especially the dynamic nature of CSCs themselves under RT and their communication with the irradiated tumor microenvironment including stromal cells and immune cells, remains to be elucidated. Further elucidation of the complexity of the irradiated local tumor microenvironment in which CSCs reside may generate significant new information to resensitize radioresistant tumor cells and thus to improve therapeutic efficacy. In this chapter, I will describe the general information on normal stem cells, CSCs, CSCs-associated tumor repopulation and energy reprogramming and potential therapeutic targets. The dynamic features of radioresistance-associated factors such as NF-κB and HER2 in some CSCs including breast cancer and GBM will be discussed.",
keywords = "Cancer stem cells, Immunoresponse, Metabolic reprogramming, Microenvironment, Radiosensitization, Radiotherapy, Tumor repopulation, Tumor resistance",
author = "Jian-Jian Li",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-3-319-53235-6_9",
language = "English (US)",
series = "Cancer Treatment and Research",
publisher = "Kluwer Academic Publishers",
number = "9783319532332",
pages = "191--221",
booktitle = "Cancer Treatment and Research",
edition = "9783319532332",

}

TY - CHAP

T1 - Cancer stem cells and tumor microenvironment in radiotherapy

AU - Li, Jian-Jian

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Ionizing radiation (IR) began to be a powerful medical modality soon after Wilhelm Röntgen’s discovery of X-rays in 1895. Today about 60% of cancer patients worldwide receive radiotherapy in their course of cancer control. In the past decades, the technology for precisely delivering tumor IR dose such as stereotactic body radiation therapy (SBRT) has been significantly enhanced, which increases the overall local tumor response and clinical benefit. However, in achieving the goal for long-term cancer control, radiotherapy (RT) has faced several major challenges including the elucidation of the microenvironment causing tumor repopulation and resistance, especially with the most aggressive tumor cells in late phase metastatic lesions. To meet this challenge, a great deal of effort has been devoted to revealing not only the mechanistic insight of tumor heterogeneity, but also the emerging complexity of the irradiated microenvironment. Such new knowledge provides the explanation for the long recognized tumor heterogeneity and tumor cell repopulation, one the major "R"s in tumor radiobiology, which involves cancer stem cells (also termed tumor-imitating cells, cancer stem-like cells, or stem like cancer cells). It is generally accepted that CSCs plays a key role in tumor adaptive radioresistance and are involved in clinical tumor response. The specific cell surface biomarkers as well as the biological topographies of CSCs in many solid tumors have been identified; some of them overlap with those detected in normal stem cells. However, the exact molecular mechanism causing the radioresistant phenotype of CSCs, especially the dynamic nature of CSCs themselves under RT and their communication with the irradiated tumor microenvironment including stromal cells and immune cells, remains to be elucidated. Further elucidation of the complexity of the irradiated local tumor microenvironment in which CSCs reside may generate significant new information to resensitize radioresistant tumor cells and thus to improve therapeutic efficacy. In this chapter, I will describe the general information on normal stem cells, CSCs, CSCs-associated tumor repopulation and energy reprogramming and potential therapeutic targets. The dynamic features of radioresistance-associated factors such as NF-κB and HER2 in some CSCs including breast cancer and GBM will be discussed.

AB - Ionizing radiation (IR) began to be a powerful medical modality soon after Wilhelm Röntgen’s discovery of X-rays in 1895. Today about 60% of cancer patients worldwide receive radiotherapy in their course of cancer control. In the past decades, the technology for precisely delivering tumor IR dose such as stereotactic body radiation therapy (SBRT) has been significantly enhanced, which increases the overall local tumor response and clinical benefit. However, in achieving the goal for long-term cancer control, radiotherapy (RT) has faced several major challenges including the elucidation of the microenvironment causing tumor repopulation and resistance, especially with the most aggressive tumor cells in late phase metastatic lesions. To meet this challenge, a great deal of effort has been devoted to revealing not only the mechanistic insight of tumor heterogeneity, but also the emerging complexity of the irradiated microenvironment. Such new knowledge provides the explanation for the long recognized tumor heterogeneity and tumor cell repopulation, one the major "R"s in tumor radiobiology, which involves cancer stem cells (also termed tumor-imitating cells, cancer stem-like cells, or stem like cancer cells). It is generally accepted that CSCs plays a key role in tumor adaptive radioresistance and are involved in clinical tumor response. The specific cell surface biomarkers as well as the biological topographies of CSCs in many solid tumors have been identified; some of them overlap with those detected in normal stem cells. However, the exact molecular mechanism causing the radioresistant phenotype of CSCs, especially the dynamic nature of CSCs themselves under RT and their communication with the irradiated tumor microenvironment including stromal cells and immune cells, remains to be elucidated. Further elucidation of the complexity of the irradiated local tumor microenvironment in which CSCs reside may generate significant new information to resensitize radioresistant tumor cells and thus to improve therapeutic efficacy. In this chapter, I will describe the general information on normal stem cells, CSCs, CSCs-associated tumor repopulation and energy reprogramming and potential therapeutic targets. The dynamic features of radioresistance-associated factors such as NF-κB and HER2 in some CSCs including breast cancer and GBM will be discussed.

KW - Cancer stem cells

KW - Immunoresponse

KW - Metabolic reprogramming

KW - Microenvironment

KW - Radiosensitization

KW - Radiotherapy

KW - Tumor repopulation

KW - Tumor resistance

UR - http://www.scopus.com/inward/record.url?scp=85018559168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018559168&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-53235-6_9

DO - 10.1007/978-3-319-53235-6_9

M3 - Chapter

T3 - Cancer Treatment and Research

SP - 191

EP - 221

BT - Cancer Treatment and Research

PB - Kluwer Academic Publishers

ER -